Menu
  • The inaugural US E-Cigarette Summit was held in Washington DC, on Monday May 8, 2017 and welcomed over 250 people
  • The 2nd Annual US E-Cigarette Summit will take place April 30, 2018......Registration is now open

Dr Konstantinos Farsalinos M.D

Research Fellow
Onassis Cardiac Surgery Greece, Department of Pharmacology, University of Patras, Greece

Konstantinos E. Farsalinos, M.D., is a research fellow at the Onassis Cardiac Surgery Center in Athens, Greece, and at the Department of Pharmacy, University of Patras, Greece. He has been conducting laboratory and clinical research on e-cigarettes as a principal investigator since 2011. Examples of his work include the first study on the cytotoxic effects of e-cigarette vapor on cultured cells and the immediate effects of e-cigarette use on cardiac function and coronary circulation. He ran a worldwide online survey of almost 20,000 vapers (users of e-cigarettes) identifying patterns of use and experience with e-cigarettes among consumers, published in 2014. He has presented his research findings at major international scientific congresses and his research was used in preparing the regulatory framework on e-cigarettes by the European Union. As of April 2017, he has published more than 50 studies and articles in international peer-reviewed scientific journals about smoking, tobacco harm reduction, and e-cigarettes. He was also the handling editor and author in a book titled “Analytical assessment of e-cigarettes”, published by Elsevier.

Competing Interest: For some of the studies, the institution has received funding from e-cigarette companies. None of the researchers received any compensation for participating to the studies.

Dr Konstantinos Farsalinos M.D will be speaking at:

Moderated Discussion and Q&A: Risk and Harm for Individual and Population Health

- 12:05 - 12:40

E-Cigarette Safety & Risk Profile – Methodology and clinical relevance

- 11:50 - 12:05

« Back to previous page